Furthermore, inhibition of CLK activity was associated with activity for regulating RPS6KB1 (S6K) splicing and inhibiting cancer cell growth, suggesting that CLK inhibitors suppress cancer cell growth by altering S6K pre-mRNA splicing [91]. The gene discussed is CLK1; the disease is cancer.